NCT01949259

Brief Summary

A retrospective, data mining project that re-uses routine patient care data for decision support systems.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 24, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

September 30, 2016

Status Verified

September 1, 2016

Enrollment Period

11 months

First QC Date

September 10, 2013

Last Update Submit

September 29, 2016

Conditions

Lung Cancer

Keywords

RetrospectiveLung cancer

Outcome Measures

Primary Outcomes (1)

  • Survival

    Retrospective data will be collected from each included patient from start of radiotherapy until end of study or death (an expected average of 10 years).

    From radiotherapy until death

Secondary Outcomes (4)

  • Local control

    From start of treatment until death,

  • Distant metastases

    From treatment until end of study

  • Dyspnea

    From inclusion until end of study

  • Dysphagia

    From treatment until end of study

Study Arms (1)

Retrospective collection

Retrospective collection of data from included lung cancer patients.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Lung cancer patients

You may qualify if:

  • \- Patients notes as suffering from lung cancer in at least one clinical data source.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MAASTRO clinic

Maastricht, Limburg, 6229 ET, Netherlands

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Andre Dekker, Dr

    Maastro Clinic, The Netherlands

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2013

First Posted

September 24, 2013

Study Start

September 1, 2013

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

September 30, 2016

Record last verified: 2016-09

Locations

NL(1)